Traders sold shares of Ishares Nasdaq Biotechnology (NASDAQ:IBB) on strength during trading on Wednesday. $30.09 million flowed into the stock on the tick-up and $65.22 million flowed out of the stock on the tick-down, for a money net flow of $35.13 million out of the stock. Of all equities tracked, Ishares Nasdaq Biotechnology had the 0th highest net out-flow for the day. Ishares Nasdaq Biotechnology traded up $0.13 for the day and closed at $110.67

Institutional investors and hedge funds have recently modified their holdings of the business. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Ishares Nasdaq Biotechnology by 200.0% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,907,625 shares of the financial services provider’s stock worth $203,677,000 after buying an additional 1,271,750 shares during the last quarter. CHURCHILL MANAGEMENT Corp boosted its stake in shares of Ishares Nasdaq Biotechnology by 223.2% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 1,801,330 shares of the financial services provider’s stock worth $192,328,000 after buying an additional 1,244,066 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of Ishares Nasdaq Biotechnology by 79.6% in the 4th quarter. Alliancebernstein L.P. now owns 1,140,301 shares of the financial services provider’s stock worth $121,750,000 after buying an additional 505,243 shares during the last quarter. Commerce Bank boosted its stake in shares of Ishares Nasdaq Biotechnology by 217.0% in the 4th quarter. Commerce Bank now owns 793,250 shares of the financial services provider’s stock worth $84,695,000 after buying an additional 543,005 shares during the last quarter. Finally, Meitav Dash Investments Ltd. purchased a new position in shares of Ishares Nasdaq Biotechnology in the 4th quarter worth $54,468,000. Institutional investors and hedge funds own 62.27% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/traders-sell-ishares-nasdaq-biotechnology-ibb-on-strength-ibb/1959491.html.

Ishares Nasdaq Biotechnology Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Receive News & Ratings for Ishares Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ishares Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.